InvestorsHub Logo
Followers 54
Posts 3479
Boards Moderated 0
Alias Born 10/26/2013

Re: Tartiaboy post# 2525

Friday, 03/01/2019 1:49:02 PM

Friday, March 01, 2019 1:49:02 PM

Post# of 3283
As an investor, when I look at blood cancer biotechs, and realizing they are only 10 % of cancers, I am somewhat disinterested in following them. I'd be more interested if they were a solid tumor biotech but treatments for all cancers are definitely needed and I hope they succeed.

TGTX just announced interim ORR data on a MZL pivotal trial.